Molecular aspects of cyclophilins mediating therapeutic actions of their ligands

Cellular and Molecular Life Sciences

Volumn 67, Issue 20, 2010, Pages 3467-3488

  Galat, Andrzej ^a   Bua, Jacqueline ^b  

^a Institute Frederic Joliot   (France)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

Cyclophilin; Cyclosporine A; Immunophilin; Immunosuppression; PPIase

Indexed keywords

CYCLOPHILIN; CYCLOSPORIN A; CYCLOSPORIN; LIGAND;

BINDING AFFINITY; BINDING SITE; CELL VIABILITY; ENZYME POLYMORPHISM; HUMAN; HYDROPHOBICITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; ISOMERIZATION; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; GENERAL ASPECTS OF DISEASE; GENETICS; METABOLISM;

HEPATITIS C VIRUS;

ANIMALS; CONSERVED SEQUENCE; CYCLOPHILINS; CYCLOSPORINE; DISEASE; HUMANS; LIGANDS;

EID: 77957357258     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0437-0     Document Type: Review

References (179)

1. Borel JF, Feurer C, Gubler HU, Stahelin H (1994) Biological effects of cyclosporine A: a new antilymphocytic agent. Agents Actions 43:179-186
2. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporine A. Science 226:544-546
3. Galat A, Riviere S (1998) Peptidylprolyl cis/trans isomerases. Oxford University Press, Oxford
4. Edlich F, Fischer G (2006) Pharmacological targeting of catalized protein folding: the example of peptide bond cis/trans isomerases. Hand Exp Pharmacol 172:359-404
5. Galat A, Bouet F (1994) Cyclophilin B is an abundant protein whose conformation is similar to that of cyclophilin A. FEBS Lett 347:31-36
6. Kieffer LJ, Thalhammer T, Handschumacher RE (1992) Isolation and characterization of a 40-kDa cyclophilin-related protein. J Biol Chem 267:5503-5507
7. Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, Pontius JU, Schuler GD, Schriml LM, Sequeira E, Tatusova TA, Wagner L (2003) Database resources of National Center for Biotechnology. Nucleic Acids Res 31:28-33
8. Bell A, Monaghan P, Page AP (2006) Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action. Int J Parasitol 36:261-276
9. Potenza M, Galat A, Minning TA, Ruiz AM, Duran R, Tarleton RL, Marín M, Fichera LE, Bua J (2006) Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of cyclosporine A binding proteins. Parasitology 132:867-882
10. Krücken J, Greif G, von Samson-Himmelstjerna G (2009) In silico analysis of the cyclophilin repertoire of apicomplexan parasites. Parasit Vectors 2:27-51
11. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporine A and FKBP-FK506 complexes. Cell 66:807-815
12. Sigal NH, Dumont F (1992) Cyclosporine A, FK506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10:519-560
13. Huai Q, Kim HY, Liu Y, Zhao Y, Mondragon A, Liu JO, Ke H (2002) Crystal structure of calcineurin-cyclophilin-cyclosporineshows common but distinct recognition of immunophilindrug complexes. Proc Natl Acad Sci USA 99:12037-12042
14. Jin L, Harrison SC (2002) Crystal structure of human calcineurin complexed with cyclosporine A and human cyclophilin. Proc Natl Acad Sci USA 99:13522-13526
15. Stahelin HF (1996) The history of cyclosporine A (Sandimmune) revisited: another point of view. Experientia 52:5-13
16. Ke H, Zydowsky LD, Liu J, Walsh CT (1991) Crystal structure of recombinant human T-cell cyclophilin A at 2.5 Å resolution. Proc Natl Acad Sci USA 88:9483-9487
17. Ke H, Huai Q (2004) Crystal structures of cyclophilin and its partners. Front Biosci 9:2285-2296
18. Reidt U, Wahl MC, Fasshauer D, Horowitz DS, Luhrmann R, Ficner R (2003) Crystal structure of a complex between human spliceosomal cyclophilin H and a U4/U6 snRNP-60K peptide. J Mol Biol 331:45-56
19. Galat A (2008) Functional drift of sequence attributes in the FK506-binding proteins (FKBPs). J Chem Inf Model 48:1118-1130
20. Loosli H-R, Kessler H, OshkiNature H Weber H-P, Petcher TJ, Widmer A (1985) The conformation of cyclosporine A in the crystal and in solution. Helv Chim Acta 68:682-704
21. Kessler H, Kock M, Wein T, Gehrke M (1990) Reinvestigation of the conformation of cyclosporine A in chloroform. Helv Chim Acta 73:1818-1832
22. Altschuh D, Braun W, Kallen J, Mikol V, Spitzfaden C, Thierry C, Vix O, Walkinshaw MD, Wuthrich K (1994) Conformational polymorphism of cyclosporine A. Structure 2:963-972
23. Wuthrich K, von Freyberg B, Weber C, Wider G, Traber R, Widmer H, Braun W (1991) Receptor-induced conformation change of the immunosuppressant cyclosporine A. Science 254:953-954
24. Zydowsky L, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA, Ho SI, Walsh CT (1992) Mutagenesis of human cyclophilin A defines the enzyme active site and separate peptidyl-prolyl isomerase activity from cyclosporin-A binding and calcineurin inhibition. Prot Sci 1:1092-1099
25. Mikol V, Kallen J, Pflugl G, Walkinshaw MD (1993) X-ray structure of a monomeric cyclophilin A-cyclosporine A crystal complex at 2.1 Å resolution. J Mol Biol 234:1119-1130
26. Kallen J, Spitzfaden C, Zurini M G M, Wider G, Widmer H, Wuthrich K, Walkinshaw MD (1991) Structure of human cyclophilin and its binding site for cyclosporine A determined by X-ray crystallography and NMR spectroscopy. Nature 353:276-279
27. Braun W, Kallen J, Mikol V, Walkinshaw MD, Wuthrich K (1995) Three-dimensional structure and actions of immunosuppressants and their immunophilins. FASEB J 9:63-72
28. Kallen J, Walkinshaw MD (1992) The X-ray structure of a tetrapeptide bound to the active site of human cyclophilin A. FEBS Lett 300:286-290
29. Eisenmesser EZ, Thai V, Pozharski E, Kern D. Mechanistic insights of cyclophilin-A from X-ray cyrstallographic and nuclear magnet resonance investigations (1ZKF). http://www.rcsb.org/pdb (accessed October 2007)
30. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP (1996) Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-1294 (Pubitemid 27010111)
31. Radzicka A, Acheson SA, Wolfenden R (1992) Cis/trans isomerization at proline: desolvation and its consequences for protein folding. Bioorg Chem 20:382-386
32. Zhao Y, Ke H (1996) Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization. Biochemistry 35:7356-7361
33. Stein RL (1993) Mechanism of enzymatic and nonenzymatic prolyl cis-trans isomerization. Adv Protein Chem 44:1-24
34. Scholz C, Scherer G, Mayr LM, Schindler T, Fischer G, Schmid FX (1998) Prolyl isomerases do not catalyze isomerization of non-prolyl peptide bonds. Biol Chem 379:361-365
35. Harrison RK, Stein RL (1990) Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. Biochemistry 29:3813-3816
36. Piotukh K, Gu W, Kofler M, Labudde D, Helms V, Freund C (2005) Cyclophilin A binds to linear peptide motifs containing a consensus that is present in many human proteins. J Biol Chem 280:23668-23674
37. MacArthur MW, Thornton JM (1991) Influence of proline residues on protein conformation. J Mol Biol 218:397-412
38. Galat A (2009) On transversal hydrophobicity of some proteins and their modules. J Chem Inf Model 49:1821-1830
39. Gibbs PR, Radzicka A, Wolfenden R (1991) The anomalous hydrophilic character of proline. J Am Chem Soc 113:4714-4715
40. Wang XJ, Etzkorn FA (2006) Peptidyl-prolyl isomerase inhibitors. Biopolymers 84:125-146
41. Galat A (1996) A large-scale processing of kinetic data files with derivation of the inhibitory constant Ki: an application to proline isomerases. Comput Chem 20:279-281
42. Papageorgiou C, Borer X, French RR (1994) Calcineurin has a very tight-binding pocket for the side chain of residue 4 of cyclosporin. Bioorg Med Chem Lett 4:267-272
43. Hu MK, Badger A, Rich DH (1995) Cyclosporine Analogs modified in the 3, 7, 8-positions: substituent effects on peptidylprolyl isomerase inhibition and immunosuppressive activity are nonadditive. J Med Chem 38:4164-4170
44. Loor F, Tiberghien F, Wenandy T, Didier A, Traber R (2002) Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter. J Med Chem 45:4598-4612
45. Loor F, Tiberghien F, Wenandy T, Didier A, Traber R (2002) Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor. J Med Chem 45:4613-4628
46. Wenger R (1986) Cyclosporine and analogues: structural requirements for immunosuppressive activity. Transplant Proc 18:213-218
47. Billich A, Hammerschmid F, Peichl P, Wenger R, Zenke G, Quesniaux V, Rosenwirth B (1995) Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporine A analog with activity against human immunodeficiency virus (HIV) type 1:interference with HIV protein-cyclophilin A interactions. J Virol 69:2451-2461
48. Fehr T, Kallen J, Oberer L, Sanglier JJ, Schilling W (1999) Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110; Structure elucidation, stereochemistry and physico-chemical properties. J Antibiot (Tokyo) 52:474-479
49. Sanglier JJ, Quesniaux V, Fehr T, Hofmann H, Mahnke M, Memmert K, Schuler W, Zenke G, Gschwind L, Maurer C, Schilling W (1999) Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110; Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) 52:466-473
50. Fehr T, Quesniaux VF, Sanglier JJ, Oberer L, Gschwind L, Ponelle M, Schilling W, Wehrli S, Enz A, Zenke G, Schuler W (1997) Cymbimicin A and B, two novel cyclophilin-binding structures isolated from actinomycetes. J Antibiot (Tokyo) 50:893-899
51. Gaymes TJ, Cebrat M, Siemion IZ, Kay JE (1997) Cyclolinopeptide A (CLA) mediates its immunosuppressive activity through cyclophilin-dependent calcineurin inactivation. FEBS Lett 418:224-227
52. Kallen J, Sedrani R, Zenke G, Wagner J (2005) Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6 Å resolution. J Biol Chem 280:21965-21971
53. Allen A, Zheng Y, Gardner L, Safford M, Horton MR, Powell JD (2004) The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol 172:4797-4803
54. Davis TL, Walker JR, Ouyang H, MacKenzie F, Butler-Cole C, Newman EM, Eisenmesser EZ, Dhe-Paganon S (2008) The crystal structure of human WD40 repeat-containing peptidylprolyl isomerase (PPWD1). FEBS J 275:2283-2295
55. Bang H, Brune K, Nager C, Feige U (1993) Interleukin-8 is a cyclosporine A binding protein. Experientia 49:533-538
56. Husi H, Zurini MG (1994) Comparative binding studies of cyclophilins to cyclosporine A and derivatives by fluorescence measurements. Anal Biochem 222:251-255
57. Galat A (2004) Function-dependent clustering of orthologues and paralogues of cyclophilins. Proteins Struct Funct Bioinform 56:808-820
58. Moparthi SB, Hammarström P, Carlsson U (2009) A nonessential role for Arg55 in cyclophilin18 for catalysis of proline isomerization during protein folding. Prot Sci 18:475-479
59. Moparthi SB, Fristedt R, Mishra R, Almstedt K, Karlsson M, Hammarström P, Carlsson U (2010) Chaperone activity of Cyp18 through hydrophobic condensation that enables rescue of transient misfolded molten globule intermediates. Biochemistry 49:1137-1145
60. Berman HM, Henrick K, Nakamura H, Markley JL (2007) The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res 35: D301-D303
61. DeLano WL (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos. (http://pymol.sourceforge.net/)
62. Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon JM, Fleming MA, Caron PR, Hsiao Navia MA (1995) X-ray structure of calcineurin inhibited by the immunophilinimmunosuppressant FKBP12-FK506 complex. Cell 82:507-522
63. Vajdos FF, Yoo S, Houseweart M, Sundquist WI, Hill CP (1997) Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Prot Sci 6:2297-2307
64. Howard BR, Vajdos FF, Li S, Sundquist WI, Hill CP (2003) Structural insights into the catalytic mechanism of cyclophilin A. Nature Struct Biol 10:475-481
65. Ingelfinger D, Göthel SF, Marahiel MA, Reidt U, Ficner R, Lührmann R, Achsel T (2003) Two protein-protein interaction sites on the spliceosome-associated human cyclophilin CypH. Nucleic Acids Res 31:4791-4796
66. Pan H, Luo C, Li R, Qiao A, Zhang L, Mines M, Nyanda AM, Zhang J, Fan GH (2008) Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration. J Biol Chem 283:623-637
67. Baum N, Schiene-Fischer C, Frost M, Schumann M, Sabapathy K, Ohlenschlager O, Grosse F, Schlott B (2009) The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis. Oncogene 28:3915-3925
68. Braaten D, Luban J (2001) Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J 20:1300-1309
69. Cantin R, Méthot S, Tremblay MJ (2005) Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol 79:6577-6587
70. Fernandes F, Ansari IU, Striker R (2010) Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A. PLoS One 5(3):e9815
71. Puyang X, Poulin DL, Mathy JE, Anderson LJ, Ma S, Fang Z, Zhu S, Lin K, Fujimoto R, Compton T, Wiedmann B (2010) Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors. Antimicrob Agents Chemother 54:1981-1987
72. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Florenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O (2002) Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 21:2261-2269
73. Kuhn AN, van Santen MA, Schwienhorst A, Urlaub H, Lührmann R (2009) Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation. RNA 15:153-175
74. Obama K, Kato T, Hasegawa S, Satoh S, Nakamura Y, Furukawa Y (2006) Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin Cancer Res 12:70-76
75. Stumpf T, Zhang Q, Hirnet D, Lewandrowski U, Sickmann A, Wissenbach U, Dorr J, Lohr C, Deitmer JW, Fecher-Trost C (2008) The Human TRPV6 channel protein is associated with cyclophilin B in human placenta. J Biol Chem 283:18086-18098
76. Schneider H, Charara N, Schmitz R, Wehrli S, Mikol V, Zurini MG, Quesniaux VF, Movva NR (1994) Human cyclophilin C: primary structure, tissue distribution, and determination of binding specificity for cyclosporins. Biochemistry 33:8218-8224
77. Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61:372-385
78. Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, Sweeney HL, Robbins J, Molkentin JD (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nature Med 14:442-447
79. Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, Rasola A (2008) Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltagedependent anion channels. PLoS ONE 3:e1852
80. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nature Med 14:1097-1105
81. Horowitz DS, Lee E, Mabon SA, Misteli T (2002) A cyclophilin functions in pre-mRNA splicing. EMBO J 21:470-480
82. Mi H, Kops O, Zimmermann E, Jaschke A, Tropschug M (1996) A nuclear RNA-binding cyclophilin in human T cells. FEBS Lett 378:201-205
83. Gudbjartsson DF, Walters GB, Thorleifsson G, Stefansson H, Halldorsson BV, Zusmanovich P, Sulem P, Thorlacius S, Gylfason A, Steinberg S, Helgadottir A, Ingason A, Steinthorsdottir V, Olafsdottir EJ, Olafsdottir GH, Jonsson T, Borch-Johnsen K, Hansen T, Andersen G, Jorgensen T, Pedersen O, Aben KK, Witjes JA, Swinkels DW, den Heijer M, Franke B, Verbeek AL, Becker DM, Yanek LR, Becker LC, Tryggvadottir L, Rafnar T, Gulcher J, Kiemeney LA, Kong A, Thorsteinsdottir U, Stefansson K (2008) Many sequence variants affecting diversity of adult human height. Nature Genet 40:609-615
84. Carrello A, Allan RK, Morgan SL, Owen BA, Mok D, Ward BK, Minchin RF, Toft DO, Ratajczak T (2004) Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70. Cell Stress Chaperones 9:167-181
85. Jang LK, Lee ZH, Kim HH, Hill JM, Kim JD, Kwon BS (2001) A novel leucine-rich repeat protein (LRR-1): potential involvement in 4-1BB-mediated signal transduction. Mol Cells 12:304-312
86. Peyrl A, Krapfenbauer K, Slavc I, Yang JW, Strobel T, Lubec G (2003) Protein profiles of medulloblastoma cell lines DAOY and D283:identification of tumor-related proteins and principles. Proteomics 3:1781-1800
87. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635-648
88. Dubourg B, Kamphausen T, Weiwad M, Jahreis G, Feunteun J, Fischer G, Modjtahedi N (2004) The human nuclear SRcyp is a cell cycle-regulated cyclophilin. J Biol Chem 279:22322-22330
89. Sakashita E, Tatsumi S, Werner D, Endo H, Mayeda A (2004) Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. Mol Cell Biol 24:1174-1187
90. Rundle NT, Nelson J, Flory MR, Joseph J, Th'ng J, Aebersold R, Dasso M, Andersen RJ, Roberge M (2006) An ent-kaurene that inhibits mitotic chromosome movement and binds the kinetochore protein Ran-binding protein 2. ACS Chem Biol 1:443-450
91. Dawlaty MM, Malureanu L, Jeganathan KB, Kao E, Sustmann C, Tahk S, Shuai K, Grosschedl R, van Deursen JM (2008) Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIα. Cell 133:103-115
92. Li Y, Li X, Stremlau M, Lee M, Sodroski J (2006) Removal of arginine 332 allows human TRIM5α to bind human immunodeficiency virus capsids and to restrict infection. J Virol 80:6738-6744
93. Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Grutter C, Martinetti G, Mazzucchelli L, Grutter M, Manz MG, Luban J (2009) Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest 119:3035-3047
94. Friedman J, Weissman I (1991) Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 66:799-806
95. Bram RJ, Hung DT, Martin PK, Schreiber SL, Crabtree GR (1993) Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporine A and FK506:roles of calcineurin binding and cellular location. Mol Cell Biol 13:4760-4769
96. Colgan J, Asmal M, Luban J (2000) Isolation, characterization and targeted disruption of mouse PPIA: cyclophilin A is not essential for mammalian cell viability. Genomics 68:167-178
97. Colgan J, Asmal M, Yu B, Luban J (2005) Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporin. J Immunol 174:6030-6038
98. Allain F, Boutillon C, Mariller C, Spik G (1995) Selective assay for CyPA and CyPB in human blood using highly specific antipeptide antibodies. J Immunol Methods 178:113-120
99. Yang H, Elmquist WF (1996) The binding of cyclosporine-A to human plasma: an in vitro microdialysis study. Pharm Res 3:622-627
100. Cacalano NA, Chen BX, Cleveland WL, Erlanger BF (1992) Evidence for a functional receptor for cyclosporine A on the surface of lymphocytes. Proc Natl Acad Sci USA 89:4353-4357
101. Malesevic M, Kuhling J, Erdmann F, Balsley MA, Bukrinsky MI, Constant SL, Fischer G (2010) A cyclosporinederivative discriminates between extracellular and intracellular cyclophilins. Angew Chem Int Ed Engl 49:213-215
102. Augustijns PF, Brown SC, Willard DH, Consler TG, Annaert PP, Hendren RW, Bradshaw TP (2000) Hydration changes implicated in the remarkable temperature-dependent membrane permeation of cyclosporine A. Biochemistry 39:7621-7630
103. Denys A, Allain F, Masy E, Dessaint JP, Spik G (1998) Enhancing the effect of secreted cyclophilin B on immunosuppressive activity of cyclosporin. Transplantation 65:1076-1084
104. Allain F, Vanpouille C, Carpentier M, Slomianny MC, Durieux S, Spik G (2002) Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc Natl Acad Sci USA 99:2714-2719
105. Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, Bergen HR 3rd, Hefferan TE, Yaszemski MJ, Bram RJ (2009) Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet 5:e1000750
106. Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, Makareeva E, Leikin S, Rotimi CN, Eyre DR, Raggio CL, Marini JC (2010) Lack of cyclophilin B in Osteogenesis imperfecta with normal collagen folding. N Engl J Med 362:521-528
107. Peng H, Vijayakumar S, Schiene-Fischer C, Li H, Purkerson JM, Malesevic M, Liebscher J, Al-Awqati Q, Schwartz GJ (2009) Secreted cyclophilin A, a peptidylprolyl cis-trans isomerase, mediates matrix assembly of hensin, a protein implicated in epithelial differentiation. J Biol Chem 284:6465-6475
108. Chang H, Brown CW, Matzuk MM (2002) Genetic analysis of the mammalian transforming growth factor-b superfamily. Endocrine Rev 23:787-823
109. Lander AD (2007) Morpheus unbound: reimagining the morphogen gradient. Cell 128:245-256
110. Kudrin A, Scott M, Martin S, Chung CW, Donn R, McMaster A, Ellison S, Ray D, Ray K, Binks M (2006) Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem 281:29641-29651
111. Kudrin A, Ray D (2008) Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol Cell Biol 86:232-238
112. Galat A, Riviere S, Bouet F, Menez A (1994) A diversified family of 12-kDa proteins with a high amino acid sequence similarity to macrophage migration-inhibitory factor (MIF). Eur J Biochem 224:417-421
113. Franke EK, Yuan H E H, Luban J (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362
114. Chatterji U, Bobardt MD, Stanfield R, Ptak RG, Pallansch LA, Ward PA, Jones MJ, Stoddart CA, Scalfaro P, Dumont JM, Besseghir K, Rosenwirth B, Gallay PA (2005) Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells. J Biol Chem 280:40293-40300
115. Strebel K, Luban J, Jeang KT (2009) Human cellular restriction factors that target HIV-1 replication. BMC Med 16 (7):48
116. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-926
117. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda DJ, Espeseth AS, Konig R, Bandyopadhyay S, Ideker T, Goff SP, Krogan NJ, Frankel AD, Young JA, Chanda SK (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5:e1000437
118. Bauer K, Kretzschmar AK, Cvijic H, Blumert C, Loffler D, Brocke-Heidrich K, Schiene-Fischer C, Fischer G, Sinz A, Clevenger CV, Horn F (2009) Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells. Oncogene 28:2784-2795
119. Torlakovic EE, Keeler V, Wang C, Lim HJ, Lining LA, Laferté S (2009) Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane. BMC Cancer 9:251
120. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR (2010) Signatures of mutation and selection in the cancer genome. Nature 463:893-898
121. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD, Jia M, Latimer C, Teague JW, Lau KW, Burton J, Quail MA, Swerdlow H, Churcher C, Natrajan R, Sieuwerts AM, Martens JW, Silver DP, Langerod A, Russnes HE, Foekens JA, Reis-Filho JS, van't Veer L, Richardson AL, Borresen-Dale AL, Campbell PJ, Futreal PA, Stratton MR (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462:1005-1010
122. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, Teague J, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Forbes S, Jia M, Jones D, Knott H, Kok CY, Lau KW, Leroy C, Lin ML, McBride DJ, Maddison M, Maguire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, O'Meara S, Pleasance E, Rajasingham A, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turrell K, Dykema KJ, Khoo SK, Petillo D, Wondergem B, Anema J, Kahnoski RJ, Teh BT, Stratton MR, Futreal PA (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463:360-363
123. Silverman JA, Hayes ML, Luft BJ, Joiner KA (1997) Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporinederivative lacking immunosuppressive and peptidyl-prolyl isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology. Antimicrob Agents Chemother 41:1859-1866
124. Berriman M, Fairlamb AH (1998) Detailed characterization of a cyclophilin from the human malaria parasite Plasmodium falciparum. Biochem J 334:437-445
125. Kumar R, Musiyenko A, Barik S (2005) Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporine A and synergism with geldanamycin. Mol Biochem Parasitol 141:29-37
126. Hirtzlin J, Farber PM, Franklin RM, Bell A (1995) Molecular and biochemical characterization of a Plasmodium falciparum cyclophilin containing a cleavable signal sequence. Eur J Biochm 232:765-772
127. Reddy GR (1995) Cloning and characterization of a Plasmodium falciparum cyclophilin gene that is stage-specifically expressed. Mol Biochem Parasitol 73:111-121
128. High KP, Joiner KA, Handschumacher RE (1994) Isolation, cDNA sequences, and biochemical characterization of the major cyclosporin-binding proteins of Toxoplasma gondii. J Biol Chem 269:9105-9112
129. Golding H, Aliberti J, King LR, Manischewitz J, Andersen J, Valenzuela J, Landau NR, Sher A (2003) Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood 102:3280-3286
130. Adams B, Musiyenko A, Kumar R, Barik S (2005) A novel class of dual-family immunophilins. J Biol Chem 280:24308-24314
131. Rascher C, Pahl A, Pecht A, Brune K, Solbach W, Bang H (1998) Leishmania major parasites express cyclophilin isoforms with an unusual interaction with calcineurin. Biochem J 334:659-667
132. Sen B, Venugopal V, Chakraborty A, Datta R, Dolai S, Banerjee R, Datta AK (2007) Amino acid residues of Leishmania donovani cyclophilin key to interaction with its adenosine kinase: biological implications. Biochemistry 46:7832-7843
133. Paape D, Barrios-Llerena ME, Le Bihan T, Mackay L, Aebischer T (2010) Gel free analysis of the proteome of intracellular Leishmania mexicana. Mol Biochem Parasitol 169:108-114
134. Hoerauf A, Rascher C, Bang R, Pahl A, Solbach W, Brune K, Rollinghoff M, Bang H (1997) Host-cell cyclophilin is important for the intracellular replication of Leishmania major. Mol Microbiol 24:421-429
135. Dutta M, Delhi P, Sinha KM, Banerjee R, Dutta AK (2001) Lack of abundance of cytoplasmic cyclosporine A-binding protein renders free-living Leishmania donovani resistant to cyclosporine A. J Biol Chem 276:19294-19300
136. Pelle R, McOdimba F, Chuma F, Wasawo D, Pearson TW, Murphy NB (2002) The African trypanosome cyclophilin A homologue contains unusual conserved central and N-terminal domains and is developmentally regulated. Gene 290:181-191
137. Bua J, Fichera LE, Fuchs A, Potenza M, Dubin M, Wenger RO, Moretti G, Scabone CM, Ruiz AM (2008) Anti-Trypanosoma cruzi effects of cyclosporine A derivatives: possible role of a P-glycoprotein and parasite cyclophilins. Parasitology 135:217-228
138. Bua J, Ruiz AM, Potenza M, Fichera LE (2004) In vitro antiparasitic activity of Cyclosporine A analogs on Trypanosoma cruzi. Bioorg Med Chem Lett 14:4633-4637
139. Ostoa-Saloma P, Cesar Carrero J, Petrossian P, Herion P, Landa A, Pedro Laclette J (2000) Cloning, characterization and functional expression of a cyclophilin of Entamoeba histolytica. Mol Biochem Parasitol 107:219-225
140. Carrero JC, Lugo H, Perez DG, Ortiz-Martinez C, Laclette JP (2004) Cyclosporine A inhibits calcineurin (phosphatase 2B) and P-glycoprotein activity in Entamoeba histolytica. Int J Parasitol 34:1091-1097
141. Yu HS, Kong HH, Chung DI (2002) Cloning and characterization of Giardia intestinalis cyclophilin. Korean J Parasitol 40:131-138
142. Perkins ME, Wu TW, Le Blancq SM (1998) Cyclosporine analogs inhibit in vitro growth of Cryptosporidium parvum. Antimicrob Agents Chemother 42:843-848
143. Gallay PA (2009) Cyclophilin inhibitors. Clin Liver Dis 13:403-417
144. Perry K, Agabian N (1991) mRNA processing in the Trypanosomatidae. Experientia 47:118-128
145. Pritchard DI (2005) Sourcing a chemical succession for cyclosporinefrom parasites and human pathogens. Drug Discov Today 10:688-691
146. Demeule M, Laplante A, Sepehr-Araé A, Murphy GM, Wenger RM, Béliveau R (2000) Association of cyclophilin A with renal brush border membranes: redistribution by cyclosporine A. Kidney Int 57:1590-1598
147. Malouitre S, Dube H, Selwood D, Crompton M (2010) Mitochondrial targeting of cyclosporine A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation. Biochem J 425:137-148
148. Siu WP, Pun PB, Latchoumycandane C, Boelsterli UA (2008) Bax-mediated mitochondrial outer membrane permeabilization (MOMP), distinct from the mitochondrial permeability transition, is a key mechanism in diclofenac-induced hepatocyte injury: multiple protective roles of cyclosporine A. Toxicol Appl Pharmacol 227:451-461
149. Norenberg MD, Rao KV (2007) The mitochondrial permeability transition in neurologic disease. Neurochem Int 50:983-997
150. Kristal BS, Stavrovskaya IG, Narayanan MV, Krasnikov BF, Brown AM, Beal MF, Friedlander RM (2004) The mitochondrial permeability transition as a target for neuroprotection. J Bioenerg Biomembr 36:309-312
151. Karlsson J, Fong KS, Hansson MJ, Elmér E, Csiszar K, Keep MF (2004) Life span extension and reduced neuronal death after weekly intraventricular cyclosporineinjections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neurosurg 101:128-137
152. Hicks D, Lampe AK, Laval SH, Allamand V, Jimenez-Mallebrera C, Walter MC, Muntoni F, Quijano-Roy S, Richard P, Straub V, Lochmüller H, Bushby KM (2009) Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue. Brain 132:147-155
153. Lee YC, Kim SH, Seo YB, Roh SS, Lee JC (2006) Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma. Int Immunopharmacol 6:703-713
154. Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S (2009) In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy. J Control Release 138:16-23
155. Manteca A, Sanchez J (2004) Recombinant cyclophilins lack nuclease activity. J Bacteriol 186:6325-6326
156. Montague JW, Gaido ML, Frye C, Cidlowski JA (1994) A calcium-dependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin. Recombinant cyclophilins A, B, and C have nuclease activity. J Biol Chem 269:18877-18880
157. Varthakavi V, Heimann-Nichols E, Smith RM, Sun Y, Bram RJ, Ali S, Rose J, Ding L, Spearman P (2008) Identification of calcium-modulating cyclophilin
158. Kuhl A, Munch J, Sauter D, Bertram S, Glowacka I, Steffen I, Specht A, Hofmann H, Schneider H, Behrens G, Pohlmann S (2010) Calcium-modulating cyclophilin ligand does not restrict retrovirus release. Nature Med 16:155-156
159. Bram RJ, Crabtree GR (1994) Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature 371:355-358
160. Hackstein H, Steinschulte C, Fiedel S, Eisele A, Rathke V, Stadlbauer T, Taner T, Thomson AW, Tillmanns H, Bein G, Hölschermann H (2007) Sanglifehrin-A blocks key dendritic cell functions in vivo and promotes long-term allograft survival together with low-dose CsA. Am J Transplant 7:789-798
161. Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, Aiello S, Cassis L, Gotti E, Gaspari F, Cattaneo D, Perico N, Remuzzi G (2007) Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 18:1007-1018
162. Wahl MC, Will CL, Lührmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701-718
163. Zhu C, Wang X, Deinum J, Huang Z, Gao J, Modjtahedi N, Neagu MR, Nilsson M, Eriksson PS, Hagberg H, Luban J, Kroemer G, Blomgren K (2007) Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 204:1741-1748
164. Le Hir M, Su Q, Weber L, Woerly G, Granelli-Piperno A, Ryffel B (1995) In situ detection of cyclosporine A: evidence for nuclear localization of cyclosporine and cyclophilins. Lab Invest 73:727-733
165. Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, Bukrinsky MI, Constant SL (2005) Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 175:517-522
166. Syed F, Rycyzyn MA, Westgate L, Clevenger CV (2003) A novel and functional interaction between cyclophilin A and prolactin receptor. Endocrine 20:83-90
167. + T cells via a prolinedirected conformational switch in Itk. Immunity 21:189-201
168. Galat A (2006) Involvement of some large immunophilins and their ligands in the protection and regeneration of neurons: a hypothetical mode of action. Comput Biol Chem 30:348-359
169. Jakob RP, Schmid FX (2009) Molecular determinants of a native-state prolyl isomerization. J Mol Biol 387:1017-1031
170. Thai V, Renesto P, Fowler CA, Brown DJ, Davis T, Gu W, Pollock DD, Kern D, Raoult D, Eisenmesser EZ (2008) Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the Mimivirus. J Mol Biol 378:71-86
171. Lummis SC, Beene DL, Lee LW, Lester HA, Broadhurst RW, Dougherty DA (2005) Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438:248-252
172. Wang X, Zhang S, Zhang J, Huang X, Xu C, Wang W, Liu Z, Wu J, Shi Y (2010) A large intrinsically disordered region in SKIP and its disorder-order transition induced by PPIL1 binding revealed by NMR. J Biol Chem 285:4951-4963
173. Weininger U, Jakob RP, Eckert B, Schweimer K, Schmid FX, Balbach J (2009) A remote prolyl isomerization controls domain assembly via a hydrogen bonding network. Proc Natl Acad Sci USA 106:12335-12340
174. Akool el-S, Doller A, Babelova A, Tsalastra W, Moreth K, Schaefer L, Pfeilschifter J, Eberhardt W (2008) Molecular mechanisms of TGFb receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporine A and FK506. J Immunol 181:2831-2845
175. Fehr T, Lucas CL, Kurtz J, Onoe T, Zhao G, Hogan T, Vallot C, Rao A, Sykes M (2010) A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo. Blood 115:1280-1287
176. Medyouf H, Alcalde H, Berthier C, Guillemin MC, dos Santos NR, Janin A, Decaudin D, de Thé H, Ghysdael J (2007) Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nature Med 13:736-741
177. Simon N, Dailly E, Combes O, Malaurie E, Lemaire M, Tillement JP, Urien S (1998) Role of lipoproteins in the plasma binding of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin. Br J Clin Pharmacol 45:173-175
178. Fischer V, Rodriguez-Gascon A, Heitz F, Tynes R, Hauck C, Cohen D, Vickers AE (1998) The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A; Implications for drug-drug interactions and pharmacological activity of the main metabolite. Drug Metab Dispos 26:802-811
179. Kawai R, Lemaire M, Steimer JL, Bruelisauer A, Niederberger W, Rowland M (1994) Physiologically based pharmacokinetic study on a cyclosporine derivative, SDZ IMM 125. J Pharmacokinet Biopharm 22:327-365